StonvexLoading…
StonvexStonvexStonvexCore line items from CZR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.87B | $11.49B | $8.57B | $5.70B |
Operating Income | $500.00M | $1.86B | $1.53B | $1.01B |
Net Income | $-98.00M | $-502.00M | $-252.00M | $-197.00M |
EPS (Diluted) | $-0.48 | $-2.42 | $-1.20 | $-0.93 |
Total Assets | $31.66B | $31.64B | $31.90B | $32.48B |
Total Liabilities | $28.07B | $27.95B | $27.93B | $28.36B |
Cash & Equivalents | $867.00M | $887.00M | $836.00M | $982.00M |
Free Cash Flow OCF − CapEx | $36.00M | $497.00M | $350.00M | $227.00M |
Shares Outstanding | 204.00M | 202.63M | 209.00M | 210.00M |